Top Story

Iluvien for DME poised to fulfill unmet need, create significant market niche

March 26, 2015

The Iluvien intravitreal implant will satisfy an unmet need among patients with diabetic macular edema and create sizeable new markets, Alimera Sciences officials said during a company-sponsored webcast.

Iluvien (fluocinolone acetonide intravitreal implant 0.19 mg) is a non-bioerodable device designed to release fluocinolone acetonide at an initial rate of 0.25 µm per day for 36 months.

Blog

BLOG: Blue light awareness – finally

March 26, 2015
I have just returned from Vision Expo East. The Vision Expos, East and West, are always packed with new information, and I, of course, enjoy catching up a bit with…
Breaking News

ThromboGenics announces positive long-term study results of Jetrea in VMA patients

March 25, 2015
ThromboGenics announced positive topline results from the OASIS study of Jetrea in patients with symptomatic vitreomacular adhesion, according to a press release.The…
FDA News

FDA approves Eylea to treat diabetic retinopathy in patients with diabetic macular edema

March 25, 2015
The FDA has approved Eylea injection to treat diabetic retinopathy in diabetic macular edema patients, according to an agency press release.Two clinical studies…
CME
Postoperative Inflammation and Pain

Postoperative Inflammation and Pain: Elimination of the Dynamic Duo to Improve Patient Outcomes

This activity is supported by an educational grant from Bausch + Lomb.

Cataract surgery has improved in both safety and outcomes in recent years. With advances in surgical techniques…
More »
Meeting News Coverage Video
thumbnail for video 4109734370001

VIDEO: OCT angiography of wet AMD and diabetes

March 15, 2015
At Retina 2015, Nadia K. Waheed, MD, discusses available OCT devices and how ophthalmologists can use the devices in…
More »
Breaking News

Iluvien for DME poised to fulfill unmet need, create significant market niche

March 26, 2015
The Iluvien intravitreal implant will satisfy an unmet need among patients with diabetic macular edema and create sizeable new markets, Alimera…
Blog

BLOG: Blue light awareness – finally

March 26, 2015
I have just returned from Vision Expo East. The Vision Expos, East and West, are always packed with new information, and I, of course, enjoy catching…
Breaking News

ThromboGenics announces positive long-term study results of Jetrea in VMA patients

March 25, 2015
ThromboGenics announced positive topline results from the OASIS study of Jetrea in patients with symptomatic vitreomacular adhesion, according to a…
FDA News

FDA approves Eylea to treat diabetic retinopathy in patients with diabetic macular edema

March 25, 2015
The FDA has approved Eylea injection to treat diabetic retinopathy in diabetic macular edema patients, according to an agency press release.Two…
In the Journals

Adverse event rates low in AMD patients who take anti-VEGFs

March 24, 2015
Patients treated with anti-VEGFs for age-related macular degeneration had a low rate of adverse events that was comparable to the rate in the general…
thumbnail for video 4131356728001 Meeting News CoverageVideo

VIDEO: Speaker discusses the advantages of swept source OCT

March 24, 2015
At Retina 2015, SriniVas Sadda, MD, discusses the advantages of swept source OCT over existing commercial SD-OCT devices.
Breaking News

Clearside reports BCVA gain in phase 1/2 trial of suprachoroidal injection of triamcinolone acetonide

March 17, 2015
Patients with noninfectious uveitis experienced an improvement in best corrected visual acuity in a phase 1/2 clinical trial involving a…
Meeting News Coverage

Volk diversifies with handheld devices

March 16, 2015
ATLANTA – Volk Optical is known for its diagnostic ophthalmic lenses, but the company is now following a diversification strategy that is…
thumbnail for video 4109734370001 Meeting News CoverageVideo

VIDEO: OCT angiography of wet AMD and diabetes

March 15, 2015
At Retina 2015, Nadia K. Waheed, MD, discusses available OCT devices and how ophthalmologists can use the devices in their clinical practice.
thumbnail for video 4107919893001 Meeting News CoverageVideo

VIDEO: PCON sponsors SECO talk on diabetes

March 13, 2015
ATLANTA – A. Paul Chous, OD, whose practice emphasizes diabetes eye care and education, updated attendees here at SECO on the epidemiological…
More Headlines »
morganatic-roan
morganatic-roan